The Rho GTPase-activating protein (RhoGAP), DLC1, has been well characterized as a tumor suppressor, as its expression was frequently found to be downregulated in various cancer types, and restoration of its expression in cancer cell lines inhibited tumorigenic growth [18, 19]. Here, ARHGAP1 is linked to cancer.